Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Necrotic, collagen-degraded dentin matrix proteins refer to the organic scaffold of the tooth's dentin layer that has been compromised by bacterial acids and endogenous proteolytic enzymes during the progression of dental caries (Goldberg et al., 2011, PMID: 21358760). Dentin is primarily composed of Type I collagen (approximately 90%) and various non-collagenous proteins (NCPs) like dentin sialophosphoprotein (DSPP) and dentin matrix protein 1 (DMP1), which are essential for regulating the mineralization of hydroxyapatite. In a diseased state, the acidic environment created by bacteria demineralizes the inorganic component, exposing the organic matrix to degradation by host-derived enzymes such as matrix metalloproteinases (MMPs) and cysteine cathepsins (Tjäderhane et al., 2015, PMID: 25634344). This degradation results in a softened, necrotic layer that lacks structural integrity and can harbor pathogenic bacteria, leading to pulp inflammation or necrosis if left untreated. Therapeutic strategies in restorative dentistry often target this degraded matrix to arrest decay and improve the longevity of dental restorations. Silver diamine fluoride (SDF) is a prominent pharmacological agent that interacts with these proteins, precipitating silver proteinates and calcium fluoride to create a hardened, antimicrobial surface layer (Mei et al., 2013, PMID: 23701310). Additionally, clinicians utilize protease inhibitors like chlorhexidine to non-specifically inhibit the activity of MMPs and cathepsins, thereby preventing further collagen breakdown and enhancing the stability of the hybrid layer formed during adhesive bonding procedures. Understanding the molecular state of this matrix is critical for developing materials that can effectively remineralize or seal the affected tooth structure.
Silver diamine fluoride precipitates silver and proteins to form a protective, hardened layer; chlorhexidine inhibits matrix metalloproteinases (MMPs) and cysteine cathepsins to prevent further enzymatic collagen degradation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Necrotic, collagen-degraded dentin matrix proteins.